Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: medRxiv, 2021.12.07.21267432, 9 S.
- Event
-
Veröffentlichung
- (where)
-
Frankfurt am Main
- (who)
-
Universitätsbibliothek Johann Christian Senckenberg
- (when)
-
2021
- Creator
-
Wilhelm, Alexander
Widera, Marek
Grikscheit, Katharina
Toptan, Tuna
Schenk, Barbara
Pallas, Christiane
Metzler, Melinda
Kohmer, Niko
Hoehl, Sebastian
Helfritz, Fabian Arnold
Wolf, Timo
Götsch, Udo
Ciesek, Sandra
- DOI
-
10.1101/2021.12.07.21267432
- URN
-
urn:nbn:de:hebis:30:3-736362
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wilhelm, Alexander
- Widera, Marek
- Grikscheit, Katharina
- Toptan, Tuna
- Schenk, Barbara
- Pallas, Christiane
- Metzler, Melinda
- Kohmer, Niko
- Hoehl, Sebastian
- Helfritz, Fabian Arnold
- Wolf, Timo
- Götsch, Udo
- Ciesek, Sandra
- Universitätsbibliothek Johann Christian Senckenberg
Time of origin
- 2021
Other Objects (12)
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Phänotyp und Funktion humaner CD1c-positiver dendritischer Zellen : Bedeutung für die Hepatitis-C-Virus-Infektion
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
Monoclonal antibodies
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
Development of antiviral strategies against positive-sense single stranded RNA viruses
Recapitulation of the hepatitis C virus life cycle in engineered murine cell lines
Utility of different surrogate enzyme-linked immunosorbent assays (sELISAs) for detection of SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Glycoengineering of Monoclonal Antibodies